Effects of Ciprofol versus Propofol on Hemodynamic Profiles During Anesthesia Induction Across Different Age Groups: A Randomized Controlled Trial
This randomized controlled trial demonstrates that ciprofol provides superior hemodynamic stability and reduces hypotension incidence compared to propofol during anesthesia induction, particularly in elderly patients, by mitigating the cardiac output-driven blood pressure decline that characterizes this age group.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Every time a patient goes under general anesthesia, their body faces a sudden, invisible challenge. The drugs used to induce sleep act quickly, but they also relax the muscles that keep blood vessels open and can slow the heart's pumping action. This often causes a sharp drop in blood pressure, a condition known as hypotension. For a healthy young person, the body usually compensates for this dip with ease. But for an older adult, whose blood vessels are stiffer and whose heart may not pump as forcefully, this drop can be dangerous, potentially starving the brain or other organs of oxygen. Anesthesiologists have long relied on a drug called propofol to put patients to sleep because it works fast and leaves the body quickly. However, a newer drug called ciprofol has emerged, promising to keep blood pressure steadier during this critical moment. The question remains: does this new drug work better for everyone, or is its advantage specific to certain patients?
A team of researchers at the Affiliated Hospital of Shandong Second Medical University set out to answer this by watching exactly what happens inside the body when these drugs are given. They enrolled 140 patients scheduled for elective surgery, dividing them into four groups based on age and the drug they received. Half the patients were younger adults between 20 and 40 years old, and the other half were older adults between 65 and 80. Within each age group, half received the new ciprofol and half received the standard propofol. To see the full picture of how the drugs affected the heart and blood vessels, the researchers used a specialized monitoring system that measured blood flow and pressure every second, rather than just checking it every few minutes. They also tracked how deep the patients were asleep to ensure that any differences in blood pressure were not simply because one group was more sedated than the other.
The results showed a clear difference in how the two drugs affected the body, and this difference depended heavily on the patient's age. When the researchers looked at the overall stability of blood pressure during the first five minutes after the drug was given, ciprofol performed significantly better than propofol in both age groups. However, the benefit was much more dramatic for the older patients. In the elderly group, those who received ciprofol experienced far fewer drops in blood pressure and required much less medication to boost their pressure back up compared to those who received propofol. In the younger group, ciprofol also helped keep blood pressure more stable, but the gap between the two drugs was smaller. The study found that the new drug did not make patients sleep any deeper or wake up any differently; the advantage was purely in how it protected the circulatory system.
To understand why this happened, the researchers looked at the mechanics of the blood pressure drop. They discovered that the body loses blood pressure for different reasons depending on age. In the younger patients, the drop was mostly caused by the blood vessels widening too much, which lowers resistance and lets pressure fall. In the older patients, the drop was driven primarily by the heart pumping less blood with each beat. The new drug, ciprofol, appeared to be gentler on the heart's pumping ability. By preserving the heart's output, it directly addressed the main cause of blood pressure loss in the elderly. In contrast, propofol caused a more significant reduction in the heart's pumping power, which proved difficult for older patients to compensate for.
This study suggests that the choice of anesthesia drug should not be one-size-fits-all. While propofol remains a standard and effective choice, ciprofol offers a distinct advantage for older adults by keeping their hearts pumping more effectively during the induction of anesthesia. The research indicates that for elderly patients, whose bodies are less able to handle a sudden drop in heart performance, this new drug provides a safer, more stable path into surgery. The findings highlight that understanding the specific physiological changes that come with aging can lead to better, more personalized medical care, ensuring that the moment of going under sleep is as safe as possible for every patient.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.